Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Histone-lysine N-methyltransferase, H3 lysine-79 specific [1-416] | ||
Ligand | BDBM244791 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | In Vitro Biological Assay | ||
IC50 | 0.73±n/a nM | ||
Citation | Klaus, C; Raimondi, MA; Daigle, SR; Pollock, RM Combination therapy for treating cancer US Patent US9446064 Publication Date 9/20/2016 | ||
More Info.: | Get all data from this article, Assay Method | ||
Histone-lysine N-methyltransferase, H3 lysine-79 specific [1-416] | |||
Name: | Histone-lysine N-methyltransferase, H3 lysine-79 specific [1-416] | ||
Synonyms: | DOT1L | DOT1L_HUMAN | Histone H3-K79 methyltransferase (DOT1L) | KIAA1814 | KMT4 | ||
Type: | Protein | ||
Mol. Mass.: | 47443.16 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q8TEK3 aa 1-416 | ||
Residue: | 416 | ||
Sequence: |
| ||
BDBM244791 | |||
n/a | |||
Name | BDBM244791 | ||
Synonyms: | US9446064, A3 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H42N8O3 | ||
Mol. Mass. | 562.7063 | ||
SMILES | CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12)[C@H]1C[C@H](CCc2nc3cc(ccc3[nH]2)C(C)(C)C)C1 |r,wU:22.24,5.4,7.12,wD:24.27,10.11,8.8,(-3.22,.18,;-1.89,.95,;-1.89,2.49,;-.55,.18,;.78,.95,;2.11,.18,;3.36,1.09,;4.61,.18,;4.13,-1.28,;4.9,-2.61,;2.59,-1.28,;1.82,-2.61,;5.38,1.52,;4.47,2.76,;5.38,4.01,;6.84,3.53,;8.17,4.3,;8.17,5.84,;9.51,3.53,;9.51,1.99,;8.17,1.22,;6.84,1.99,;-.55,-1.36,;.54,-2.44,;-.55,-3.53,;-.55,-5.07,;-1.89,-5.84,;-3.22,-5.07,;-3.24,-3.61,;-4.89,-3.22,;-5.66,-1.89,;-7.2,-1.89,;-7.97,-3.22,;-7.2,-4.56,;-5.66,-4.56,;-4.63,-5.7,;-7.97,-.55,;-8.74,.78,;-9.51,-.55,;-7.2,.78,;-1.64,-2.44,)| | ||
Structure |